Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Frederick Langford who wrote (582)	3/31/1999 1:59:00 PM
From: Raven McCloud	Read Replies (2) of 2515

Okay, Frederick, I check out his thread. However, given how far out IMCL is to FDA approval and all the impt. pieces that will need to fall in place for that approval, I don't see why a shorter like AP, "who almost NEVER goes long" as you say would now go long with IMCL. Doesn't jive in my "short" book that's for sure. I detect a hidden agenda here on AP's part. The reality is that we're at least 12 months away, at least, even with fast track, and then there's no certainty. Now on a TA level, IMCL is primed to move down. As I said before Sochastics is way, way oversold. There'll be some consolidation here, IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next